Cargando…

PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP

PURPOSE: Soluble epoxide hydrolase (sEH) is a promising candidate positron emission tomography (PET) imaging biomarker altered in various disorders, including vascular cognitive impairment (VCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and depression, known to regulate levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yong, Minn, Il, Foss, Catherine, Lesniak, Wojciech G., Hu, Feng, Dannals, Robert F., Pomper, Martin G., Horti, Andrew G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310027/
https://www.ncbi.nlm.nih.gov/pubmed/32572592
http://dx.doi.org/10.1186/s13550-020-00657-7
_version_ 1783549289374416896
author Du, Yong
Minn, Il
Foss, Catherine
Lesniak, Wojciech G.
Hu, Feng
Dannals, Robert F.
Pomper, Martin G.
Horti, Andrew G.
author_facet Du, Yong
Minn, Il
Foss, Catherine
Lesniak, Wojciech G.
Hu, Feng
Dannals, Robert F.
Pomper, Martin G.
Horti, Andrew G.
author_sort Du, Yong
collection PubMed
description PURPOSE: Soluble epoxide hydrolase (sEH) is a promising candidate positron emission tomography (PET) imaging biomarker altered in various disorders, including vascular cognitive impairment (VCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and depression, known to regulate levels of epoxyeicosatrienoic acids (EETs) and play an important role in neurovascular coupling. [(18)F]FNDP, a PET radiotracer for imaging sEH, was evaluated through quantitative PET imaging in the baboon brain, radiometabolite analysis, and radiation dosimetry estimate. METHODS: Baboon [(18)F]FNDP dynamic PET studies were performed at baseline and with blocking doses of the selective sEH inhibitor AR-9281 to evaluate sEH binding specificity. Radiometabolites of [(18)F]FNDP in mice and baboons were measured by high-performance liquid chromatography. Regional brain distribution volume (V(T)) of [(18)F]FNDP was computed from PET using radiometabolite-corrected arterial input functions. Full body distribution of [(18)F]FNDP was studied in CD-1 mice, and the human effective dose was estimated using OLINDA/EXM software. RESULTS: [(18)F]FNDP exhibited high and rapid brain uptake in baboons. AR-9281 blocked [(18)F]FNDP uptake dose-dependently with a baseline V(T) of 10.9 ± 2.4 mL/mL and a high-dose blocking V(T) of 1.0 ± 0.09 mL/mL, indicating substantial binding specificity (91.70 ± 1.74%). The V(ND) was estimated as 0.865 ± 0.066 mL/mL. The estimated occupancy values of AR-9281 were 99.2 ± 1.1% for 1 mg/kg, 88.6 ± 1.3% for 0.1 mg/kg, and 33.8 ± 3.8% for 0.02 mg/kg. Murine biodistribution of [(18)F]FNDP enabled an effective dose estimate for humans (0.032 mSv/MBq). [(18)F]FNDP forms hydrophilic radiometabolites in murine and non-human primate plasma. However, only minute amounts of the radiometabolites entered the animal brain (< 2% in mice). CONCLUSIONS: [(18)F]FNDP is a highly sEH-specific radiotracer that is suitable for quantitative PET imaging in the baboon brain. [(18)F]FNDP holds promise for translation to human subjects.
format Online
Article
Text
id pubmed-7310027
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73100272020-06-24 PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP Du, Yong Minn, Il Foss, Catherine Lesniak, Wojciech G. Hu, Feng Dannals, Robert F. Pomper, Martin G. Horti, Andrew G. EJNMMI Res Original Research PURPOSE: Soluble epoxide hydrolase (sEH) is a promising candidate positron emission tomography (PET) imaging biomarker altered in various disorders, including vascular cognitive impairment (VCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and depression, known to regulate levels of epoxyeicosatrienoic acids (EETs) and play an important role in neurovascular coupling. [(18)F]FNDP, a PET radiotracer for imaging sEH, was evaluated through quantitative PET imaging in the baboon brain, radiometabolite analysis, and radiation dosimetry estimate. METHODS: Baboon [(18)F]FNDP dynamic PET studies were performed at baseline and with blocking doses of the selective sEH inhibitor AR-9281 to evaluate sEH binding specificity. Radiometabolites of [(18)F]FNDP in mice and baboons were measured by high-performance liquid chromatography. Regional brain distribution volume (V(T)) of [(18)F]FNDP was computed from PET using radiometabolite-corrected arterial input functions. Full body distribution of [(18)F]FNDP was studied in CD-1 mice, and the human effective dose was estimated using OLINDA/EXM software. RESULTS: [(18)F]FNDP exhibited high and rapid brain uptake in baboons. AR-9281 blocked [(18)F]FNDP uptake dose-dependently with a baseline V(T) of 10.9 ± 2.4 mL/mL and a high-dose blocking V(T) of 1.0 ± 0.09 mL/mL, indicating substantial binding specificity (91.70 ± 1.74%). The V(ND) was estimated as 0.865 ± 0.066 mL/mL. The estimated occupancy values of AR-9281 were 99.2 ± 1.1% for 1 mg/kg, 88.6 ± 1.3% for 0.1 mg/kg, and 33.8 ± 3.8% for 0.02 mg/kg. Murine biodistribution of [(18)F]FNDP enabled an effective dose estimate for humans (0.032 mSv/MBq). [(18)F]FNDP forms hydrophilic radiometabolites in murine and non-human primate plasma. However, only minute amounts of the radiometabolites entered the animal brain (< 2% in mice). CONCLUSIONS: [(18)F]FNDP is a highly sEH-specific radiotracer that is suitable for quantitative PET imaging in the baboon brain. [(18)F]FNDP holds promise for translation to human subjects. Springer Berlin Heidelberg 2020-06-22 /pmc/articles/PMC7310027/ /pubmed/32572592 http://dx.doi.org/10.1186/s13550-020-00657-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Du, Yong
Minn, Il
Foss, Catherine
Lesniak, Wojciech G.
Hu, Feng
Dannals, Robert F.
Pomper, Martin G.
Horti, Andrew G.
PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP
title PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP
title_full PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP
title_fullStr PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP
title_full_unstemmed PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP
title_short PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP
title_sort pet imaging of soluble epoxide hydrolase in non-human primate brain with [(18)f]fndp
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310027/
https://www.ncbi.nlm.nih.gov/pubmed/32572592
http://dx.doi.org/10.1186/s13550-020-00657-7
work_keys_str_mv AT duyong petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp
AT minnil petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp
AT fosscatherine petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp
AT lesniakwojciechg petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp
AT hufeng petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp
AT dannalsrobertf petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp
AT pompermarting petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp
AT hortiandrewg petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp